Telmisartan clinical trials
Also written Micardis and Pritor.
Its developmentBy 15 companies, company by company130 company-led studies, furthest phase 4: when each phase was reached, its deals, target and what is ahead.How each study uses Telmisartan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Telmisartan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 10 Nov 1998 · MICARDIS · NDA 020850 (FDA, Drugs@FDA)
- European Union
- 11 Dec 1998 · Pritor · EMEA/H/C/000210 (EMA; now withdrawn)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- BIBR 277
- 1
Studies by the year they started
177 studies that test it; most in 2007 (18)
| Year | Studies |
|---|---|
| 1997 | 1 |
| 1998 | 8 |
| 1999 | 4 |
| 2000 | 7 |
| 2001 | 5 |
| 2002 | 7 |
| 2003 | 6 |
| 2004 | 4 |
| 2005 | 8 |
| 2006 | 13 |
| 2007 | 18 |
| 2008 | 3 |
| 2009 | 8 |
| 2010 | 7 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 10 |
| 2015 | 8 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 10 |
| 2021 | 6 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 6 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 111 · Other 66
Boehringer Ingelheim (72) · Chong Kun Dang Pharmaceutical (12) · Yuhan Corporation (4) · IlDong Pharmaceutical Co Ltd (4) · The George Institute (3) · Jeil Pharmaceutical Co., Ltd. (3) · George Medicines PTY Limited (2) · ANRS, Emerging Infectious Diseases (2)
Often tested with
Tested in the same studies.
Amlodipine (26) · Hydrochlorothiazide (21) · Rosuvastatin (17) · Ramipril (11) · Ezetimibe (9) · Levamlodipine (8) · Losartan (8) · CKD-348 (6)
Related medicines
As reviewed, each with the page that says it.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 4
Studies that test Telmisartan.
- Jan 2027Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer PatientsPhase 1/2 · Tanta University
- Apr 2027A Clinical Trial to Evaluate the Drug-drug Interactions of Co-administered 'HUC2-744-A' and 'HUC2-744-B' in Healthy Adult VolunteersPhase 1 · Huons Co., Ltd.
- Apr 2027Telmisartan in Prostate CancerPhase 1 · Tyler J Curiel
- Apr 2027Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian CancerPhase 2 · Tyler J Curiel
Studies
Open first, then newest update. How each study uses Telmisartan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 177
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationPhase 4Baylor Research InstituteNCT07547878Written as MicardisHow we know
- A Clinical Trial to Evaluate the Drug-drug Interactions of Co-administered 'HUC2-744-A' and 'HUC2-744-B' in Healthy Adult VolunteersNot yet recruitingPhase 1Huons Co., Ltd.NCT07784608Written as TelmisartanHow we know
- Telmisartan in Prostate CancerRecruitingPhase 1Tyler J CurielNCT06168487Written as TelmisartanHow we know
- Relying on Pharmacotherapy to Improve Motor Gains in Chronic Stroke SurvivorsRecruitingEarly Phase 1Spaulding Rehabilitation HospitalNCT07588932Written as Telmisartan, Metformin, CilostazolHow we know
- Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite AthletesEnrolling by invitationNot applicableEnhanced Emirates LimitedNCT07568574Written as TelmisartanHow we know
- Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer PatientsNot yet recruitingPhase 1/2Tanta UniversityNCT07370506Written as TelmisartanHow we know
- Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian CancerRecruitingPhase 2Tyler J CurielNCT06815497Written as TelmisartanHow we know
- Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform TrialRecruitingPhase 3University College, LondonNCT07207057Written as TelmisartanHow we know
- Efficacy and Safety of Telmisartan Compared With LosartanRecruitingPhase 4Chong Kun Dang PharmaceuticalNCT06431477Written as telmisartanHow we know
- A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic SyndromeNot yet recruitingPhase 4Chong Kun Dang PharmaceuticalNCT05843162Written as TelmisartanHow we know
- Efficacy and Safety of HB-1 for Panic DisorderTerminatedPhase 2HB BioTech, LLCNCT06483789Written as Telmisartan Only Product in Oral Dose FormHow we know
- Study of Antihypertensive Treatment and Cardiovascular Risk in Chinese Prehypertensive PopulationCompletedNot applicableQilu Hospital of Shandong UniversityNCT07652567Written as TelmisartanHow we know
- Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for AggravationCompletedPhase 2/3University Hospital, BordeauxNCT04356495Written as TelmisartanHow we know
- Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell TransplantationTerminatedNot applicableHackensack Meridian HealthNCT02338232Written as TelmisartanHow we know
- Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts TrialCompletedPhase 3The George InstituteNCT02699645Written as telmisartan 20mg, amlodipine 2.5mg, and indapamide 1.25mgHow we know
- INTERVENCION TrialCompletedPhase 4PrevencionNCT02373163Written as TelmisartanHow we know
- Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of HypertensionCompletedPhase 3George Medicines PTY LimitedNCT04518306Written as Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mgHow we know
- Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of HypertensionCompletedPhase 3George Medicines PTY LimitedNCT04518293Written as Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mgHow we know
- Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease PatientsTerminatedPhase 2Sunnybrook Health Sciences CentreNCT02085265Written as TelmisartanHow we know
- SAFE-CRP: Structural Alterations and Function of Endothelium in Cardiovascular Risk PatientsTerminatedPhase 4Boehringer IngelheimNCT00274105Written as telmisartanHow we know
See all 177 studies that test Telmisartan →
Given beside what is tested · 13 — Telmisartan is usual care or a partner of the new treatment
- A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348CompletedPhase 1Chong Kun Dang PharmaceuticalNCT04660370Written as CKD-828, D097, D337How we know
- Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?TerminatedPhase 3University of British ColumbiaNCT04606563Written as TelmisartanHow we know
- A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348CompletedPhase 1Chong Kun Dang PharmaceuticalNCT04587206Written as CKD-828, D097, D337How we know
- Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS StudyCompletedPhase 4Heart Care FoundationNCT00421863Written as Micardis 80 mgHow we know
- The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers VolunteersCompletedPhase 1Jeil Pharmaceutical Co., Ltd.NCT03707899Written as Telmisartan/Amlodipine, RosuvastatinHow we know
- The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers VolunteersCompletedPhase 1Jeil Pharmaceutical Co., Ltd.NCT03247140Written as Telmisartan/Amlodipine, RosuvastatinHow we know
- Add-on to Micamlo BP TrialCompletedPhase 3Boehringer IngelheimNCT01975246Written as Telmisartan + amlodipineHow we know
- Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus AmlodipineCompletedPhase 3Boehringer IngelheimNCT01911780Written as telmisartan + HCTZHow we know
- Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Male and Female VolunteersCompletedPhase 1Boehringer IngelheimNCT02259777Written as Telmisartan/AmlodipineHow we know
- Telmisartan/Hydrochlorothiazide (HCTZ) Fixed Dose Combination Compared to Its Monocomponents in Healthy SubjectsCompletedPhase 1Boehringer IngelheimNCT02176512Written as BIBR 277 SE and HCTZHow we know
- Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe HypertensionCompletedPhase 4Boehringer IngelheimNCT00926289Written as TelmisartanHow we know
- Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.CompletedPhase 1Chong Kun Dang PharmaceuticalNCT01842256Written as Telmisartan 80mg, S-amlodipine 5mg and Atorvastatin 40mgHow we know
- Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric PatientsCompletedPhase 3Heidelberg UniversityNCT00221845Written as Add-on Angiotensin Receptor BlockadeHow we know
As the comparator · 18 — what is tested is compared with Telmisartan
- Early Mineralocorticoid Receptor Antagonist Therapy for Low-Renin Essential HypertensionNot yet recruitingPhase 4China National Center for Cardiovascular DiseasesNCT07932145Written as TelmisartanHow we know
- Efficacy and Safety of Egito Association in the Treatment of Type II Diabetes Mellitus and HypertensionWithdrawnPhase 3EMSNCT04970108Written as Empagliflozin + telmisartanHow we know
- Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With HypertensionCompletedPhase 4Yuhan CorporationNCT03267329Written as TelmisartanHow we know
- HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With ProteinuriaStatus unknownPhase 4Yuhan CorporationNCT03550859Written as Telmisartan 40mgHow we know
- The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan MonotherapyCompletedPhase 4Chong Kun Dang PharmaceuticalNCT02231788Written as Telmitrend®Tab. 80mgHow we know
- A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-RCompletedPhase 4TakedaNCT02079805Written as TelmisartanHow we know
- Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive PatientsCompletedPhase 2Novartis PharmaceuticalsNCT00939588Written as Telmisartan/ RamiprilHow we know
- CKD-828 (80/5mg) Pharmacokinetic StudyCompletedPhase 1Chong Kun Dang PharmaceuticalNCT02358824Written as TelmisartanHow we know
- CKD-828 (80/5mg) Pharmacokinetic StudyCompletedPhase 1Chong Kun Dang PharmaceuticalNCT02250833Written as TelmisartanHow we know
- Bioequivalence of Telmisartan / HCTZ Fixed Dose Combination Compared to Its Monocomponents in Healthy Male VolunteersCompletedPhase 1Boehringer IngelheimNCT02262624Written as TelmisartanHow we know
- Relative Bioavailability of Telmisartan and HCTZ in Two Experimental Formulations Compared to the Standard Formulation Telmisartan and HCTZ in Healthy Female and Male SubjectsCompletedPhase 1Boehringer IngelheimNCT02262572Written as Telmisartan /HCTZ - present commercial formulationHow we know
- Bioequivalence of Telmisartan / HCTZ of Fixed Dose Combination Compared to Its Monocomponents in Healthy Male VolunteersCompletedPhase 1Boehringer IngelheimNCT02262598Written as TelmisartanHow we know
- Relative Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male VolunteersCompletedPhase 1Boehringer IngelheimNCT02259803Written as TelmisartanHow we know
- Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male VolunteersCompletedPhase 1Boehringer IngelheimNCT02259790Written as TelmisartanHow we know
- Bioavailability of Lacidipine and Telmisartan Fixed Dose Combination Tablets Relative to Separate Tablets in Healthy SubjectsCompletedPhase 1Boehringer IngelheimNCT02209649Written as TelmisartanHow we know
- Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and HyperlipidemiaCompletedPhase 3Yuhan CorporationNCT01914432Written as TelmisartanHow we know
- CKD-828 Telmisartan Non-Responder TrialCompletedPhase 3Chong Kun Dang PharmaceuticalNCT01426100Written as Telmisartan 80mgHow we know
- Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment WithdrawalCompletedPhase 4NovartisNCT00865020Written as TelmisartanHow we know
Codes
What other systems call Telmisartan · ClinicalTrials.gg INT006700
- MeSH (NLM) D000077333TelmisartanConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) U5SYW473RQTELMISARTANConfirmed FDA, NLM, Wikidata
- RxNorm 73494Confirmed FDA, Wikidata
- Wikidata Q733186telmisartanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47746TelmisartanOne source FDA
- DrugBank DB00966One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077333 | Telmisartan | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | U5SYW473RQ | TELMISARTAN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 73494 | — | Confirmed FDA, Wikidata |
| Wikidata | Q733186 | telmisartan | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47746 | Telmisartan | One source FDA |
| DrugBank | DB00966 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.